# BOSENTAN
> **ANDA213154** · Abbreviated New Drug Application (Generic) · Sponsor: NATCO PHARMA LTD · Approved 2025-02-05
## Drug
- **FDA Application Number:** ANDA213154
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BOSENTAN
- **Generic name:** BOSENTAN
- **Active ingredients:** BOSENTAN
- **Dosage form:** TABLET, FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NATCO PHARMA LTD
- **Manufacturer:** Lupin Pharmaceuticals, Inc.
- **First approval:** 2025-02-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213154)
---
*AI Analytics · CC0 1.0*